XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

The following table summarizes stock option activity for the nine months ended September 30, 2023.

 

Number of
Options

 

Weighted-
Average
Exercise
Price

 

Weighted-
Average
Remaining
Contractual
Term (In Years)

 

Aggregate
Intrinsic
Value
(In Thousands)

 

Outstanding at December 31, 2022

 

2,640,590

 

$

16.19

 

 

8.08

 

$

25,513

 

Granted

 

181,246

 

 

41.48

 

 

 

 

 

Exercised

 

(175,191

)

 

11.38

 

 

 

 

 

Forfeited

 

(17,684

)

 

15.00

 

 

 

 

 

Expired

 

(70,430

)

 

102.56

 

 

 

 

 

Outstanding at September 30, 2023

 

2,558,531

 

$

15.95

 

 

7.77

 

$

86,191

 

Exercisable at September 30, 2023

 

1,285,226

 

$

16.00

 

 

6.84

 

$

46,219

 

Summary of Fair Value of Stock Option Granted

The weighted-average assumptions used to estimate the fair value of stock options granted were as follows:

 

Nine Months Ended
September 30,

 

2023

 

2022

 

Risk-free interest rate

 

3.87

%

 

2.24

%

Expected term (in years)

 

7.14

 

 

6.00

 

Expected volatility

 

59

%

 

55

%

Expected dividend yield

 

0

%

 

0

%

Fair value per share of common stock

$

41.48

 

$

13.41

 

Schedule of Restricted Stock Unit Activity

A summary of restricted common stock activity is as follows:

 

Nine Months Ended
September 30,

 

2023

 

2022

 

Unvested at the beginning of the year

 

1,916

 

 

10,170

 

Vested

 

(1,916

)

 

(6,854

)

Unvested at the end of the period

 

 

 

3,316

 

 

Summary of Stock-based Compensation Expense

Total stock-based compensation expense recorded as research and development and general and administrative expenses, respectively, for employees, directors and non-employees is as follows (in thousands):

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

2023

 

2022

 

 

2023

 

2022

 

Research and development

$

455

 

$

140

 

 

$

1,167

 

$

422

 

General and administrative

 

815

 

 

242

 

 

 

2,436

 

 

674

 

Total stock-based compensation expense

$

1,270

 

$

382

 

 

$

3,603

 

$

1,096